Crescent Grove Advisors’s Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock) SMFG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-39,845
Closed -$250K – 292
2022
Q1
$250K Sell
39,845
-30,455
-43% -$217K 0.02% 253
2021
Q4
$477K Buy
70,300
+300
+0.4% +$2.03K 0.04% 171
2021
Q3
$491K Buy
70,000
+470
+0.7% +$3.27K 0.05% 156
2021
Q2
$481K Buy
69,530
+55,906
+410% +$401K 0.05% 153
2021
Q1
$99K Buy
+13,624
New +$94.9K 0.01% 209

Other funds holding SMFG

Crescent Grove Advisors's SMFG Position: Q2 2022 in Review

Crescent Grove Advisors sold out of Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock) (SMFG) in Q2 2022, closing a stake of 39,845 shares — an estimated $250K sold.

Crescent Grove Advisors first reported a position in SMFG in Q1 2021 and held it in 5 quarters. The position peaked at $491K in Q3 2021. 244 funds tracked by Wall St. Rank hold SMFG as of Q2 2022.

  • Crescent Grove Advisors reported no remaining Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock) position as of Q2 2022 after selling out during the quarter.
  • Crescent Grove Advisors sold 39,845 Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock) shares in Q2 2022, an estimated $250K.
  • Crescent Grove Advisors first reported a position in Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock) in Q1 2021 and held it in 5 quarters.
  • Crescent Grove Advisors's Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock) position peaked at $491K in Q3 2021.
  • 244 funds tracked by Wall St. Rank held Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock) as of Q2 2022.

Based on Crescent Grove Advisors's 13F filing for Q2 2022, filed 20 Jul 2022.